معرفی
John Jackson is a Researcher at Monash University's Centre for Medicine Use and Safety within the Faculty of Pharmacy and Pharmaceutical Sciences. With over two decades of research output spanning from 2001 to 2024, he has established himself as a leading expert in medication safety, opioid dependence treatment, and community pharmacy practice. His work contributes significantly to healthcare policy development and implementation of innovative pharmacist-led services.
Mr. Jackson holds a Master of Public Health (2003), a Graduate Diploma in Hospital Pharmacy (1981), and a Bachelor of Pharmacy (1973). He serves as an external advisor to the Western Pacific Pharmaceutical Forum since 2013, demonstrating his regional influence in pharmaceutical practice.
His research interests focus on optimizing medication use through collaborative care models, particularly in the treatment of opioid dependence. He has pioneered the development and evaluation of pharmacist-prescriber collaborative models for Medication Assisted Treatment for Opioid Dependence (MATOD), addressing critical treatment shortages in Australia. His policy analyses of the Australian Community Pharmacy Agreement reveal important insights about the intersection of industry interests and public health objectives.
Mr. Jackson's publication record shows a clear progression from foundational work on medication safety toward innovative service delivery models. His recent work (2022-2024) centers on implementation science, evaluating the effectiveness of collaborative care models for opioid dependence treatment and analyzing policy environments that influence pharmacist performance. These studies represent a shift toward translating research into practical healthcare solutions.
- Pharmacist of the Year (2018)
As a Chief Investigator on multiple major projects, Mr. Jackson has secured significant research funding, including the current project 'Upscaling a pharmacist-prescriber model of collaborative care for Medication Assisted Treatment for Opioid Dependence (MATOD) to address Australia's treatment shortage' (2025-2029). His work extends beyond academia through media engagement, with notable contributions including 'Pay pharmacists to improve our health, not just supply medicines' (2019) and commentary on pharmacist workforce issues (2021).
Mr. Jackson works within the Centre for Medicine Use and Safety, collaborating with interdisciplinary teams to develop and implement evidence-based medication services that improve patient outcomes while addressing systemic challenges in healthcare delivery.
